NYSE$CHE
Chemed Corp · Q2 2020 earnings
Q2 2020 earnings · · Investor relations
Briefing
Chemed's Q2 2020 earnings were reported, with revenue increasing and adjusted EPS surpassing the previous year.
Chemed Corporation reported a 6.0% increase in revenue to $502 million. GAAP diluted EPS increased by 62.7% to $5.01, and adjusted diluted EPS increased by 31.3% to $4.41.
- Consolidated revenue increased by 6.0% to $502 million.
- GAAP diluted EPS increased by 62.7% to $5.01.
- Adjusted diluted EPS increased by 31.3% to $4.41.
- Roto-Rooter's quarterly revenue increased by 8.6% to $175 million.
Headline financials
Revenue & EPS history
Chemed · Revenue · Quarterly
$502M
Revenue by segment
Chemed · $502M total across 2 segments · Q2 2020
- VITAS Healthcare$327M—65.1%
- Roto-Rooter$175M—34.9%
Forward guidance
Chemed provided full-year 2020 adjusted earnings per diluted share guidance, excluding certain non-cash expenses and discrete items, estimated to be in the range of $16.20 to $16.40.
Tailwinds
- VITAS revenue growth is estimated to be in the range of 5% to 7%.
- Average Daily Census is estimated to expand approximately 2% to 4%.
- Adjusted EBITDA margin is estimated to be 19% to 20%.
- Roto-Rooter is forecasted to achieve full-year revenue growth of 9% to 10%.
- Roto-Rooter’s Adjusted EBITDA margin is estimated to be in the range of 23% to 25%.
Headwinds
- The pandemic will continue to materially disrupt all aspects of the healthcare system and general economy.
- Governmental decisions have the potential for an immediate and material impact on VITAS and Roto-Rooter operating results.
- Medicare Cap billing limitations for calendar year 2020 are estimated at $17 million.
- Future rules, regulations and government mandates could materially impact Chemed's ability to achieve its guidance.
- Chemed’s full year adjusted earnings per share guidance eliminates any financial benefit from the CARES Act funds that relate to lost revenue.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2020
+0.7%
Avg return
Earnings day
+0.9%
Avg return
5 days after
+2.1%
Avg return
30 days after
53%
36 / 68 earnings
Positive
+13.0%
Q3 2015
Best reaction
-14.8%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | -0.1% | +4.0% | |
| Q4 2025 | -14.8% | -9.1% | -21.0% | |
| Q3 2025 | +6.0% | +0.4% | +0.1% | |
| Q1 2025 | -6.6% | -1.8% | -2.7% | |
| Q4 2024 | +7.4% | +7.7% | +11.0% | |
| Q3 2024 | -12.0% | -12.7% | -6.2% | |
| Q2 2024 | -0.1% | +2.4% | +5.7% | |
| Q1 2024 | -7.0% | -8.1% | -9.9% | |
| Q4 2023 | +5.1% | +2.6% | +7.3% | |
| Q3 2023 | +9.3% | +10.9% | +14.4% | |
| Q2 2023 | -8.1% | -8.0% | -10.8% | |
| Q1 2023 | -3.7% | -2.2% | -4.1% | |
| Q4 2022 | +3.3% | +1.7% | +1.9% | |
| Q3 2022 | +3.2% | +4.1% | +12.6% | |
| Q2 2022 | -6.8% | -9.2% | -8.3% | |
| Q1 2022 | -1.4% | -1.0% | +0.8% | |
| Q4 2021 | +5.1% | +5.8% | +3.8% | |
| Q3 2021 | +9.2% | +9.0% | +9.4% | |
| Q2 2021 | -4.4% | -0.4% | -2.4% | |
| Q1 2021 | +1.5% | +2.3% | +6.1% | |
| Q4 2020 | -0.8% | -6.7% | -3.9% | |
| Q3 2020 | +1.2% | +3.5% | +0.2% | |
| Q2 2020 | +9.0% | +10.3% | +12.2% | |
| Q1 2020 | -3.9% | -6.5% | +5.6% | |
| Q4 2019 | +3.2% | -1.2% | -23.1% | |
| Q3 2019 | -1.7% | +0.6% | +5.9% | |
| Q2 2019 | +3.7% | +8.1% | +13.9% | |
| Q1 2019 | -0.6% | +0.7% | +0.3% | |
| Q4 2018 | +1.3% | +2.8% | +1.9% | |
| Q3 2018 | +6.2% | +6.6% | +7.6% | |
| Q2 2018 | +0.4% | -2.5% | +0.1% | |
| Q1 2018 | +3.0% | +3.3% | +13.4% | |
| Q4 2017 | +2.4% | +2.1% | +12.9% | |
| Q3 2017 | +9.1% | +5.0% | +12.7% | |
| Q2 2017 | -1.1% | -2.3% | -6.3% | |
| Q1 2017 | +10.0% | +9.4% | +9.0% | |
| Q4 2016 | +1.9% | +2.0% | +9.1% | |
| Q3 2016 | -0.3% | +1.8% | +6.3% | |
| Q2 2016 | +5.0% | +3.0% | -7.9% | |
| Q1 2016 | -6.7% | — | — | |
| Q4 2015 | -5.6% | — | — | |
| Q3 2015 | +13.0% | — | — | |
| Q2 2015 | +5.1% | — | — | |
| Q1 2015 | -4.7% | — | — | |
| Q4 2014 | +7.5% | — | — | |
| Q3 2014 | -1.2% | — | — | |
| Q2 2014 | +4.3% | — | — | |
| Q1 2014 | -3.3% | — | — | |
| Q4 2013 | +10.5% | — | — | |
| Q3 2013 | -5.2% | — | — | |
| Q2 2013 | -7.3% | — | — | |
| Q1 2013 | +3.4% | — | — | |
| Q4 2012 | +4.9% | — | — | |
| Q3 2012 | -2.0% | — | — | |
| Q2 2012 | +5.1% | — | — | |
| Q1 2012 | +2.9% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | +1.5% | — | — | |
| Q2 2011 | -5.8% | — | — | |
| Q1 2010 | -2.6% | — | — | |
| Q1 2011 | +1.8% | — | — | |
| Q4 2008 | -1.6% | — | — | |
| Q4 2010 | -1.6% | — | — | |
| Q3 2009 | +1.4% | — | — | |
| Q3 2010 | +1.4% | — | — | |
| Q2 2010 | -0.9% | — | — | |
| Q2 2009 | -0.9% | — | — | |
| Q4 2009 | -0.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro